<<

PROVINCE OF BRITISH COLUMBIA

Minis/erial Order No. 301 (

ORDER OF THE MINISTER OF HEALTH

Pharmacy Operations and Drug Scheduling Act

I, Lynn Stevenson, Associate Deputy Miruster, Ministry of Health, order that the board of the College of Pharmacists of British Columbia may, on or after the date of this Order, deposit with the Registrar of Regulations the amendments to the Drug Schedules Regulation, B.C. Reg. 9/98, that are set out in the schedule to the attached resolution of the board dated June 18,2015.

Lynn Stevens;;" Associate Deputy Minister, Ministry olHealth

(This par' islor adminislrative purposes only and Is not pari of the Order.)

Aut hority under which Order is made; Act and section:­ Pharmacy Operations and Drug Scheduling Act, S.B.C. 2003, c. 77, s. 22 (2.3) Other (specify):- Interpretation Act, R.S.B.C. 1996, c. 238, s. 23 ( I); OTC 234/2013 SUBMISSION: Resolution No. April 17, 2015 (Drug Schedules Regulation)

(

Resolution of the Board of the College of Pharmacists of British Columbia made the 18th day of June, 2015, at Vancouver, British Columbia.

RESOLVED THAT, in accordance with the authority established in section 22(1) of the Pharmacy Operations and Drug Scheduling Act, and subject to filing with the Minister as required by section 22(2) of" the Pharmacy Operations and Drug Scheduling Act, the board amend the Drug Schedules Regulation, B.C . Reg . 9/98, as set out in the schedule attached to this resolution .

Certified a true copy

Suzanne Solven Deputy Registrar

FILED MINISTRY OF HEALTH AUG 2 5 2015 SIGNATURE: f?-:f' C; i:c­ NAME· L'IDQ stevenson TITLE: •

( '1/ II') ) ,

ApPENDIX

1 The, Drug Schedules Regukltio",!, B.C. Reg. 9/98, is amended in the Schedules (a) by striking out the following: 3 Acyclovir and its salts (in topical preparations in concentrations of S% or less) Acyclovir and its salts (except in topical preparations in concentrations of 5% or less) 1 Adrenocortical hormones and their salts and derivativesV (except (a) or , when sold as a single medicinal ingredient in a concentration that provides 0.5% or less hydrocortisone in preparations for topical use on the skin, and (b) butyrate, when sold in a concentration of 0.05% c1obetasone butyrate in cream preparations for topical use on the skin) 2 Azelaic acid Hydrocortisonev (except when sold as a single medicinal ingredient in a concentration that provides 0.5% hydrocortisone in preparations for topical use on the skin) 3 Hydrocortisone (when sold as a single medicinal ingredient in a concentration that provides 0.5% hydrocortisone in preparations for topical use on the skin) 1 Hydrocortisone acetateV (except when sold as a single medicinal ingredient in a concentration that provides 0.5% hydrocortisone in preparations for topical use on the skin) , 3 Hydrocortisone acetate (when sold as a single medicinal ingredient in a concentration that provides 0.5% hydrocortisone in preparations for topical use on the skin) Naproxen and its salts (except when sold for oral use with a daily dosage of 440mg), and (b) by adding thefollowing: 1 Acyclovir and its salts

V I Adrenocortical hormones and their salts and derivatives , inCluding} but not limited to, hydrocortisone, hydrocortisone acetate, . hydrocortisone sodium succinate, clobetasone butyrate, difiuprednate and acetonide (except (a) hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides I % or less hydrocortisone in preparations for topical use on the skin, (b) hydrocortisone or hydrocortisone acetate, when sold in combination with any other non-prescription medicinal ingredient that provides 1% or less hydrocortisone in preparations for topical use on the skin, (c) clobetasone butyrate, when sold in a concentration of 0.05% clobetasone butyrate in creampreparations for topical use on the skin, and (d) in an aqueous nasal spray that delivers 55 meg per metered spray for adults and children 12 years of age and older) 1 Azelaic acid

c page 1 of2 "'I' fl') Y ,

1 Hydrocortisone or hydrocortisone acetateV (except when sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin, for adults and children 2 years of age and over, and in package sizes containing no more than 30 g) 3 Hydrocortisone or hydrocortisone acetate (when sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin, for adults and children 2 years of age and over, and in package sizes containing no more than 30 g) . Naproxen and its salts (except when sold as naproxen sodium 220 mg per oral dosage unit) . 2 Triamcinolone acetonide in an aqueous nasal spray that delivers 55 meg per metered spray for adults and children 12 years of age and older, in package sizes containing more than 120 metered sprays 3 Triamcinolone acetonide in an aqueous nasal spray that delivers 55 mcg per metered spray for adults and children 12 years of age and older, in package sizes containing no more than 120 metered sprays.

[May 4, 2015J I For administrative purposes only ~ RJ30912015133 J

( page2of2